News and Events
Cole Drifka, PhD, recently joined CTSI as Biorepository and Laboratory Services (BLS) Manager.
In this role, Dr. Drifka will manage and develop a state-of-the-art integrated biorepository to serve the needs of investigators who require access to human specimens for their research.
“The Committee for Pharmaceutical Development infused new life into our treatment idea, and propelled it toward clinical trials. We would not be where we’re at now without its support.”
- U of M Professor Greg Beilman, MD, referring to a treatment that could help people survive severe blood loss
CTSI has released a new RFA for the Translational Product Development Fund, which supports projects that have the potential to be commercialized, such as projects that may lead to the formation of a start-up company or execution of a license agreement with an established commercial entity.
CTSI’s Office of Discovery and Translation (ODAT) recently hired Angela Fralish for the newly created ODAT Research Fellow position.
As a fellow, Angela will assess the translational potential of technologies under consideration for ODAT support or currently supported through one of six ODAT funding programs
A University of Minnesota research team found that early childhood care and education providers are making significant strides in ensuring kids eat healthy food and are physically active.
Findings are from a follow-up survey to a 2010 study that was jointly funded by CTSI and the Institute for Clinical and Translational Research at the University of Wisconsin-Madison.